Thursday, June 12, 2025
- Advertisement -spot_img

TAG

Medical Conditions

BioNTech Revenue Falls. Why the Stock Is Climbing Anyway.

BioNTech Revenue Falls. Why the Stock Is Climbing Anyway. Source link

Moderna Posts Earnings Beat. There’s Good News on Covid Vaccines Too.

“We are having discussions with Europe to supply Europe for the fall of ’23,” ...

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from...

China’s Big Comeback Is Just Getting Started. How to Play It.

Talk about a comeback. As China abandons policies that stifled economic growth for the past three...

This Bull Market Is Far From Over, Pros Say. Where They’re Investing Now.

One yr in the past, U.S. shares have been simply starting to get better from the...

Moderna’s Vaccine Has Been a Success. Buy the Stock Because There’s More Coming in Its Pipeline.

Moderna, a drugmaker with simply a single product to its title, has turn into maybe the...

Latest news

- Advertisement -spot_img